0
0
0
Raising awareness for the sarcoma cancer chordoma.
3/3/2025, 4:33 PM
Summary of Bill HRES 172
Bill 119 H.Res. 172, also known as the "Raising Awareness for Sarcoma Cancer Chordoma" bill, is a piece of legislation introduced in the US Congress with the aim of increasing awareness about the rare form of cancer known as chordoma. Chordoma is a type of sarcoma cancer that affects the bones of the skull and spine, and is often difficult to diagnose and treat.
The bill highlights the need for increased research funding and resources to better understand and combat chordoma. It also calls for greater public awareness and education about the disease, in order to improve early detection and treatment outcomes.
If passed, the bill would designate July as "Chordoma Cancer Awareness Month" and encourage individuals, organizations, and communities to participate in activities and events to raise awareness about the disease. Additionally, the bill would urge healthcare providers to educate themselves and their patients about chordoma, in order to improve diagnosis and treatment options. Overall, Bill 119 H.Res. 172 seeks to bring attention to the challenges faced by individuals with chordoma, and to promote efforts to improve research, diagnosis, and treatment for this rare form of cancer.
The bill highlights the need for increased research funding and resources to better understand and combat chordoma. It also calls for greater public awareness and education about the disease, in order to improve early detection and treatment outcomes.
If passed, the bill would designate July as "Chordoma Cancer Awareness Month" and encourage individuals, organizations, and communities to participate in activities and events to raise awareness about the disease. Additionally, the bill would urge healthcare providers to educate themselves and their patients about chordoma, in order to improve diagnosis and treatment options. Overall, Bill 119 H.Res. 172 seeks to bring attention to the challenges faced by individuals with chordoma, and to promote efforts to improve research, diagnosis, and treatment for this rare form of cancer.
Read the Full Bill
Current Status of Bill HRES 172
Bill HRES 172 is currently in the status of Introduced to House since February 27, 2025. Bill HRES 172 was introduced during Congress 119 and was introduced to the House on February 27, 2025. Bill HRES 172's most recent activity was Referred to the House Committee on Energy and Commerce. as of February 27, 2025
Bipartisan Support of Bill HRES 172
Total Number of Sponsors
3Democrat Sponsors
3Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
4Democrat Cosponsors
4Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HRES 172
Primary Policy Focus
HealthAlternate Title(s) of Bill HRES 172
Raising awareness for the sarcoma cancer chordoma.
Raising awareness for the sarcoma cancer chordoma.
Comments
Sponsors and Cosponsors of HRES 172
Latest Bills
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Internal Revenue Service relating to "Beginning of Construction Requirements for Purposes of the Termination of Clean Electricity Production Credits and Clean Electricity Investment Credits for Applicable Wind and Solar Facilities".
Bill SJRES 107March 27, 2026
Recreational Drone Empowerment Act
Bill HR 6460March 27, 2026
To amend title VII of the Public Health Service Act to strengthen the mental health workforce, and for other purposes.
Bill HR 7787March 27, 2026
Farm Freedom to Repair Act
Bill HR 7850March 27, 2026
Airport Regulatory Relief Act of 2025
Bill HR 6427March 27, 2026
Medical Records Access Fairness Act of 2026
Bill HR 7790March 27, 2026
Aviation Supply Chain Safety and Security Digitization Act of 2025
Bill HR 6267March 27, 2026
Review Every Veteran’s Claim Act of 2025
Bill S 1657March 27, 2026
Ensuring Veterans’ Final Resting Place Act of 2025
Bill S 1116March 27, 2026
Restoring the Secondary Trading Market Act
Bill HR 7127March 27, 2026




